Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy plus Dexrazoxane in Newly-Diagnosed Non-Metastatic Osteosarcoma
NCT00003937Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Sep 1999
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of ifosfamide, etoposide, dexrazoxane in osteosarcoma (OS), sponsored by Children's Oncology Group. Started Sep 1999; status: completed.
02
Drugs
ifosfamideetoposidedexrazoxane
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT00003937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003937.